Medical - Pharmaceuticals Stocks
The companies in this industry manufacture and process pharmaceutical products in the treatment of health disorders and illnesses. Demand for pharmaceuticals is driven by the desire to cure illness and disease. The profitability of individual companies depends on their ability to discover and market new drugs.
Share This Page
B
Industry Rank
This industry ranks #3 out of 123 stock categories.
B
Average POWR Rating
The average market cap-weighted POWR Rating for stocks in this industry is B (Buy).
| Rk | Symbol | Name | Last | Open | High | Low | 52WK Hi | 52WK Lo | Day Chg | YTD Chg | 12M Chg | Mkt Cap | 50D MA | ± 50D | 200D MA | ± 200D | POWR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NVO | Novo Nordisk A/S | 70.22 | 69.61 | 70.46 | 69.50 | 70.46 | 49.24 | 1.05 (1.52%) |
23.21% | 36.01% | 165.35B | 66.64 | 5.38% | 62.52 | 12.32% |
A Strong Buy |
| 2 | ZTS | Zoetis Inc. | 162.48 | 161.62 | 163.41 | 161.44 | 165.82 | 90.14 | 1.16 (0.72%) |
23.31% | 31.14% | 77.20B | 156.97 | 3.51% | 137.86 | 17.86% |
A Strong Buy |
| 3 | BGNE | BeiGene, Ltd. | 281.46 | 279.77 | 284.45 | 272.30 | 284.45 | 114.41 | 0.81 (0.29%) |
69.80% | 131.48% | 25.44B | 239.09 | 17.72% | 183.62 | 53.28% |
A Strong Buy |
| 4 | HZNP | Horizon Therapeutics Public Limited Company - Ordinary Shares | 78.16 | 79.31 | 80.01 | 78.02 | 82.60 | 23.81 | -1.51 (-1.90%) |
115.91% | 183.70% | 16.14B | 71.67 | 9.06% | 47.73 | 63.76% |
A Strong Buy |
| 5 | RDY | Dr. Reddy's Laboratories Ltd | 68.65 | 68.66 | 68.88 | 68.37 | 73.50 | 33.33 | -0.36 (-0.52%) |
70.07% | 75.62% | 11.38B | 61.13 | 12.30% | 49.93 | 37.49% |
A Strong Buy |
| 6 | NVCR | NovoCure Limited - Ordinary Shares | 109.00 | 108.72 | 110.79 | 108.21 | 110.98 | 53.40 | 0.68 (0.63%) |
29.35% | 48.42% | 11.02B | 84.27 | 29.34% | 75.35 | 44.66% |
A Strong Buy |
| 7 | MYOK | MyoKardia, Inc. | 134.13 | 134.00 | 135.78 | 131.85 | 137.84 | 42.65 | 0.23 (0.17%) |
84.03% | 162.08% | 7.11B | 109.21 | 22.82% | 83.72 | 60.21% |
A Strong Buy |
| 8 | MNTA | Momenta Pharmaceuticals, Inc. | 52.49 | 52.47 | 52.50 | 52.45 | 52.50 | 12.21 | 0.03 (0.06%) |
166.04% | 282.30% | 6.25B | 43.15 | 21.66% | 32.80 | 60.05% |
A Strong Buy |
| 9 | MDGL | Madrigal Pharmaceuticals, Inc. | 119.22 | 121.55 | 121.94 | 118.00 | 127.25 | 56.82 | -2.38 (-1.96%) |
30.85% | 40.04% | 1.84B | 108.79 | 9.59% | 96.52 | 23.52% |
A Strong Buy |
| 10 | JNJ | Johnson & Johnson | 147.06 | 147.60 | 147.92 | 146.06 | 157.00 | 109.16 | -0.05 (-0.03%) |
2.84% | 14.35% | 387.18B | 148.25 | -0.80% | 143.58 | 2.42% |
B Buy |
| 11 | MRK | Merck & Company, Inc. (new) | 81.90 | 82.67 | 83.15 | 81.70 | 92.64 | 65.25 | -0.86 (-1.04%) |
-7.82% | -1.22% | 207.14B | 82.55 | -0.79% | 80.51 | 1.73% |
B Buy |
| 12 | PFE | Pfizer, Inc. | 36.17 | 36.43 | 36.54 | 36.03 | 40.97 | 27.88 | -0.22 (-0.60%) |
-4.89% | -0.14% | 200.99B | 37.47 | -3.46% | 35.89 | 0.79% |
B Buy |
| 13 | NVS | Novartis AG | 87.04 | 88.10 | 88.10 | 86.68 | 99.84 | 69.18 | -0.01 (-0.01%) |
-5.91% | -0.41% | 199.21B | 86.37 | 0.78% | 87.21 | -0.20% |
B Buy |
| 14 | ABT | Abbott Laboratories | 105.19 | 106.01 | 106.41 | 104.92 | 114.19 | 61.61 | 0.75 (0.72%) |
22.60% | 28.53% | 186.24B | 103.12 | 2.01% | 91.05 | 15.53% |
B Buy |
| 15 | AZN | Astrazeneca PLC | 55.11 | 54.71 | 55.20 | 54.71 | 64.94 | 36.15 | 0.36 (0.66%) |
13.61% | 21.71% | 144.63B | 55.56 | -0.81% | 50.79 | 8.50% |
B Buy |
| 16 | LLY | Eli Lilly and Company | 146.26 | 147.98 | 148.44 | 145.93 | 170.75 | 101.36 | -1.84 (-1.24%) |
12.94% | 30.16% | 139.89B | 151.90 | -3.71% | 146.40 | -0.10% |
B Buy |
| 17 | SNY | Sanofi - ADR | 50.50 | 50.73 | 51.00 | 48.43 | 55.00 | 37.62 | -0.50 (-0.98%) |
3.07% | 9.17% | 126.46B | 51.39 | -1.73% | 48.85 | 3.39% |
B Buy |
| 18 | CTLT | Catalent, Inc. | 85.19 | 83.95 | 85.82 | 83.55 | 95.70 | 31.04 | 1.08 (1.28%) |
51.31% | 79.54% | 14.01B | 86.08 | -1.03% | 68.24 | 24.84% |
B Buy |
| 19 | ELAN | Elanco Animal Health Incorporated | 26.76 | 26.92 | 27.44 | 26.65 | 32.66 | 15.17 | -0.30 (-1.11%) |
-9.13% | 1.36% | 10.67B | 26.04 | 2.78% | 25.15 | 6.39% |
B Buy |
| 20 | BBIO | BridgeBio Pharma, Inc. | 37.10 | 36.93 | 37.92 | 36.25 | 48.36 | 14.23 | 0.26 (0.71%) |
5.85% | 84.30% | 4.54B | 31.57 | 17.53% | 31.42 | 18.09% |
B Buy |
| 21 | MOR | MorphoSys AG | 31.89 | 31.58 | 32.03 | 31.50 | 37.96 | 18.21 | 0.21 (0.66%) |
-10.60% | 16.09% | 4.20B | 32.19 | -0.92% | 30.65 | 4.03% |
B Buy |
| 22 | DNLI | Denali Therapeutics Inc. | 36.30 | 35.33 | 36.53 | 35.32 | 39.22 | 12.39 | 1.03 (2.92%) |
108.38% | 129.17% | 3.85B | 31.01 | 17.04% | 24.46 | 48.38% |
B Buy |
| 23 | PCRX | Pacira BioSciences, Inc. | 59.39 | 59.28 | 60.03 | 58.48 | 64.44 | 27.46 | 0.02 (0.03%) |
31.10% | 48.47% | 2.54B | 58.76 | 1.07% | 47.07 | 26.16% |
B Buy |
| 24 | MESO | Mesoblast Limited | 19.19 | 19.39 | 19.44 | 18.60 | 21.28 | 3.12 | -0.25 (-1.29%) |
160.38% | 183.46% | 2.25B | 16.44 | 16.76% | 11.01 | 74.33% |
B Buy |
| 25 | AIMT | Aimmune Therapeutics, Inc. | 34.35 | 34.33 | 34.41 | 34.32 | 37.00 | 10.09 | 0.03 (0.09%) |
2.63% | 64.59% | 2.25B | 22.33 | 53.84% | 21.85 | 57.21% |
B Buy |
| 26 | MYOV | Myovant Sciences Ltd. Common Shares | 15.65 | 16.18 | 17.21 | 15.57 | 23.04 | 4.14 | -5.44 (-25.79%) |
0.84% | 201.54% | 1.41B | 18.69 | -16.27% | 14.60 | 7.16% |
B Buy |
| 27 | TRIL | Trillium Therapeutics Inc. | 13.55 | 13.68 | 14.09 | 13.28 | 16.89 | 0.24 | -0.10 (-0.73%) |
1,215.53% | 4,150.31% | 1.33B | 10.50 | 29.02% | 6.29 | 115.58% |
B Buy |
| 28 | RTRX | Retrophin, Inc. | 18.62 | 18.05 | 19.02 | 18.03 | 21.92 | 8.98 | 0.54 (2.99%) |
31.13% | 56.73% | 947.87M | 19.15 | -2.76% | 16.68 | 11.65% |
B Buy |
| 29 | CLLS | Cellectis S.A. | 18.56 | 18.50 | 18.66 | 18.04 | 21.97 | 7.32 | 0.06 (0.32%) |
8.41% | 79.32% | 788.54M | 17.81 | 4.22% | 16.07 | 15.48% |
B Buy |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 20.25 | 20.11 | 21.34 | 20.11 | 23.25 | 4.47 | 0.21 (1.05%) |
187.23% | 53.99% | 745.34M | 19.20 | 5.48% | 12.61 | 60.53% |
B Buy |
| 31 | RDHL | Redhill Biopharma Ltd. | 10.23 | 9.98 | 10.34 | 9.93 | 11.35 | 3.26 | 0.25 (2.51%) |
68.53% | 41.30% | 360.81M | 8.53 | 19.90% | 6.66 | 53.67% |
B Buy |
| 32 | SURF | Surface Oncology, Inc. | 6.50 | 6.43 | 6.64 | 6.32 | 7.75 | 1.15 | 0.01 (0.15%) |
245.74% | 364.29% | 259.39M | 6.12 | 6.25% | 3.97 | 63.83% |
B Buy |
| 33 | ATXI | Avenue Therapeutics, Inc. | 10.90 | 10.81 | 11.15 | 10.81 | 12.34 | 4.96 | -0.01 (-0.09%) |
13.54% | 87.29% | 182.06M | 11.02 | -1.10% | 9.81 | 11.15% |
B Buy |
| 34 | ETON | Eton Pharmaceuticals, Inc. | 7.82 | 7.86 | 8.00 | 7.39 | 9.12 | 2.50 | -0.19 (-2.37%) |
8.61% | 26.13% | 163.88M | 7.20 | 8.68% | 5.93 | 31.98% |
B Buy |
| 35 | ACRS | Aclaris Therapeutics, Inc. | 2.56 | 2.59 | 2.63 | 2.44 | 3.34 | 0.70 | -0.01 (-0.39%) |
35.45% | 115.13% | 109.37M | 2.32 | 10.50% | 1.66 | 54.34% |
B Buy |
| 36 | ABBV | AbbVie Inc. | 86.89 | 87.11 | 87.28 | 86.31 | 101.28 | 62.55 | -0.39 (-0.45%) |
2.18% | 16.09% | 153.35B | 93.00 | -6.57% | 87.80 | -1.03% |
C Neutral |
| 37 | BMY | Bristol-Myers Squibb Company | 59.90 | 59.84 | 60.94 | 59.68 | 68.34 | 45.76 | 0.19 (0.32%) |
-4.52% | 19.28% | 135.54B | 60.47 | -0.94% | 60.03 | -0.22% |
C Neutral |
| 38 | GSK | GlaxoSmithKline PLC | 37.43 | 37.60 | 37.85 | 37.27 | 48.25 | 31.43 | -0.43 (-1.14%) |
-17.47% | -11.60% | 93.89B | 39.75 | -5.84% | 40.84 | -8.34% |
C Neutral |
| 39 | ACAD | ACADIA Pharmaceuticals Inc. | 40.41 | 40.10 | 40.93 | 39.88 | 58.72 | 30.02 | 0.18 (0.45%) |
-5.54% | 9.87% | 6.37B | 40.32 | 0.23% | 44.18 | -8.52% |
C Neutral |
| 40 | ALLO | Allogene Therapeutics, Inc. | 37.72 | 37.28 | 37.84 | 36.67 | 55.00 | 17.43 | 0.46 (1.23%) |
45.19% | 38.42% | 5.25B | 36.36 | 3.75% | 32.25 | 16.94% |
C Neutral |
| 41 | UTHR | United Therapeutics Corporation | 101.04 | 101.82 | 101.82 | 100.09 | 127.79 | 75.58 | -0.47 (-0.46%) |
14.71% | 24.99% | 4.49B | 107.73 | -6.21% | 104.89 | -3.67% |
C Neutral |
| 42 | AXSM | Axsome Therapeutics, Inc. | 72.28 | 72.07 | 74.00 | 70.00 | 109.94 | 13.64 | -4.18 (-5.47%) |
-30.07% | 227.21% | 2.69B | 77.02 | -6.15% | 79.63 | -9.23% |
C Neutral |
| 43 | ALKS | Alkermes plc - Ordinary Shares | 16.53 | 17.02 | 17.29 | 16.49 | 21.88 | 11.98 | -0.36 (-2.13%) |
-18.97% | -15.79% | 2.63B | 17.83 | -7.28% | 17.63 | -6.21% |
C Neutral |
| 44 | APLS | Apellis Pharmaceuticals, Inc. | 28.89 | 29.63 | 30.21 | 28.74 | 45.04 | 16.85 | -0.97 (-3.25%) |
-5.65% | 18.26% | 2.18B | 29.25 | -1.24% | 32.27 | -10.49% |
C Neutral |
| 45 | EIDX | Eidos Therapeutics, Inc. | 50.07 | 50.62 | 50.93 | 48.31 | 66.56 | 28.39 | -0.37 (-0.73%) |
-12.75% | 36.65% | 1.93B | 43.87 | 14.14% | 48.24 | 3.79% |
C Neutral |
| 46 | AUPH | Aurinia Pharmaceuticals Inc | 14.56 | 14.36 | 14.66 | 14.30 | 21.93 | 3.52 | 0.20 (1.39%) |
-28.13% | 167.16% | 1.84B | 14.33 | 1.63% | 16.27 | -10.50% |
C Neutral |
| 47 | YMAB | Y-mAbs Therapeutics, Inc. | 40.50 | 38.30 | 41.18 | 38.30 | 50.49 | 14.16 | 2.17 (5.66%) |
29.60% | 57.28% | 1.62B | 39.66 | 2.13% | 35.36 | 14.54% |
C Neutral |
| 48 | ZEAL | Zealand Pharma A/S | 37.10 | 36.54 | 38.00 | 36.54 | 44.60 | 22.00 | 0.91 (2.51%) |
11.75% | 44.24% | 1.48B | 36.27 | 2.30% | 35.29 | 5.12% |
C Neutral |
| 49 | APHA | Aphria Inc. Common Shares | 4.34 | 4.30 | 4.44 | 4.27 | 6.15 | 1.95 | 0.03 (0.70%) |
-16.86% | -20.66% | 1.25B | 4.70 | -7.58% | 4.22 | 2.85% |
C Neutral |
| 50 | AMRX | Amneal Pharmaceuticals, Inc. | 3.85 | 3.84 | 3.92 | 3.76 | 5.79 | 2.40 | 0.00 (0.00%) |
-20.12% | 20.31% | 1.15B | 4.18 | -7.89% | 4.25 | -9.36% |
C Neutral |
| 51 | SUPN | Supernus Pharmaceuticals, Inc. | 20.86 | 20.71 | 20.94 | 20.31 | 29.36 | 13.12 | 0.08 (0.38%) |
-12.06% | -24.06% | 1.10B | 22.41 | -6.93% | 22.03 | -5.33% |
C Neutral |
| 52 | ATNX | Athenex, Inc. | 12.15 | 12.25 | 12.29 | 11.81 | 18.35 | 5.63 | -0.12 (-0.98%) |
-20.43% | -3.38% | 992.97M | 11.80 | 3.00% | 11.88 | 2.26% |
C Neutral |
| 53 | RYTM | Rhythm Pharmaceuticals, Inc. | 22.27 | 22.51 | 22.84 | 21.82 | 32.24 | 12.99 | -0.14 (-0.62%) |
-3.01% | 5.10% | 982.53M | 23.23 | -4.13% | 20.32 | 9.58% |
C Neutral |
| 54 | REPL | Replimune Group, Inc. | 23.31 | 21.51 | 23.40 | 21.51 | 27.69 | 8.58 | 1.73 (8.02%) |
62.44% | 73.96% | 939.11M | 22.88 | 1.89% | 18.27 | 27.58% |
C Neutral |
| 55 | AMPH | Amphastar Pharmaceuticals, Inc. | 18.63 | 18.49 | 18.68 | 18.29 | 22.69 | 12.32 | 0.12 (0.65%) |
-3.42% | -7.86% | 884.66M | 19.92 | -6.47% | 18.68 | -0.24% |
C Neutral |
| 56 | COLL | Collegium Pharmaceutical, Inc. | 19.88 | 18.76 | 20.25 | 18.75 | 25.59 | 10.43 | 1.10 (5.86%) |
-3.40% | 73.62% | 686.38M | 18.23 | 9.05% | 19.45 | 2.20% |
C Neutral |
| 57 | ALBO | Albireo Pharma, Inc. | 32.64 | 32.72 | 33.07 | 31.80 | 49.00 | 11.26 | -0.26 (-0.79%) |
28.40% | 54.91% | 489.31M | 30.05 | 8.61% | 24.86 | 31.32% |
C Neutral |
| 58 | CDMO | Avid Bioservices, Inc. | 7.69 | 7.50 | 7.75 | 7.42 | 9.10 | 3.02 | 0.19 (2.53%) |
0.26% | 46.34% | 435.28M | 7.69 | -0.02% | 6.48 | 18.73% |
C Neutral |
| 59 | VKTX | Viking Therapeutics, Inc. | 5.93 | 5.96 | 6.00 | 5.85 | 8.87 | 3.26 | -0.06 (-1.00%) |
-26.06% | -14.55% | 431.45M | 6.90 | -14.06% | 6.66 | -10.97% |
C Neutral |
| 60 | STRO | Sutro Biopharma, Inc. | 10.29 | 10.31 | 10.45 | 10.03 | 13.91 | 6.00 | -0.02 (-0.19%) |
-6.45% | 10.29% | 369.19M | 9.67 | 6.44% | 9.91 | 3.88% |
C Neutral |
| 61 | MEIP | MEI Pharma, Inc. | 3.15 | 3.08 | 3.15 | 3.00 | 4.46 | 0.72 | 0.06 (1.94%) |
27.02% | 85.29% | 354.44M | 2.88 | 9.27% | 2.65 | 19.00% |
C Neutral |
| 62 | AMAG | AMAG Pharmaceuticals, Inc. | 9.27 | 9.17 | 9.33 | 9.07 | 13.53 | 4.41 | 0.04 (0.43%) |
-23.83% | -23.39% | 319.63M | 9.92 | -6.54% | 8.86 | 4.68% |
C Neutral |
| 63 | XERS | Xeris Pharmaceuticals, Inc. | 5.84 | 5.78 | 5.89 | 5.67 | 10.13 | 1.42 | 0.09 (1.57%) |
-17.16% | -39.42% | 270.29M | 4.28 | 36.43% | 4.14 | 41.03% |
C Neutral |
| 64 | RFL | Rafael Holdings, Inc. Class B | 16.37 | 16.50 | 16.50 | 15.80 | 23.76 | 9.40 | -0.03 (-0.18%) |
-8.24% | -16.18% | 258.92M | 16.45 | -0.46% | 15.99 | 2.40% |
C Neutral |
| 65 | KALV | KalVista Pharmaceuticals, Inc. | 12.63 | 12.44 | 13.16 | 12.44 | 18.96 | 5.61 | -0.19 (-1.48%) |
-29.08% | 6.49% | 226.18M | 12.59 | 0.34% | 12.49 | 1.15% |
C Neutral |
| 66 | EPIX | ESSA Pharma Inc. | 7.00 | 7.03 | 7.10 | 6.93 | 8.31 | 3.00 | -0.03 (-0.43%) |
27.27% | 115.38% | 220.60M | 6.94 | 0.87% | 5.53 | 26.63% |
C Neutral |
| 67 | CKPT | Checkpoint Therapeutics, Inc. | 2.79 | 2.70 | 3.06 | 2.67 | 4.50 | 1.05 | 0.17 (6.49%) |
62.21% | 11.60% | 167.51M | 2.53 | 10.46% | 1.96 | 42.18% |
C Neutral |
| 68 | ACRX | AcelRx Pharmaceuticals, Inc. | 1.43 | 1.54 | 1.57 | 1.42 | 2.50 | 0.70 | -0.10 (-6.54%) |
-32.23% | -35.29% | 129.16M | 1.27 | 12.36% | 1.43 | -0.33% |
C Neutral |
| 69 | UMRX | Unum Therapeutics Inc. | 2.25 | 2.28 | 2.37 | 2.21 | 3.72 | 0.29 | -0.08 (-3.43%) |
212.41% | 41.51% | 95.56M | 2.63 | -14.59% | 1.22 | 83.77% |
C Neutral |
| 70 | ARDS | Aridis Pharmaceuticals Inc. | 7.20 | 7.28 | 7.50 | 7.18 | 10.18 | 3.80 | 0.05 (0.70%) |
61.80% | 9.59% | 64.25M | 7.03 | 2.47% | 6.58 | 9.45% |
C Neutral |
| 71 | VBLT | Vascular Biogenics Ltd. - Ordinary Shares | 1.18 | 1.10 | 1.20 | 1.10 | 1.64 | 0.90 | 0.06 (5.36%) |
-1.67% | -5.72% | 49.48M | 1.26 | -6.66% | 1.29 | -8.48% |
C Neutral |
| 72 | TENX | Tenax Therapeutics, Inc. | 1.55 | 1.55 | 1.62 | 1.52 | 2.68 | 0.25 | -0.01 (-0.64%) |
9.93% | 30.25% | 19.56M | 1.42 | 9.20% | 1.12 | 38.04% |
C Neutral |
| 73 | GRFS | Grifols, S.A. | 16.81 | 16.91 | 17.22 | 16.67 | 25.73 | 13.40 | -0.09 (-0.53%) |
-27.82% | -16.53% | 11.56B | 17.32 | -2.92% | 20.15 | -16.57% |
D Sell |
| 74 | TEVA | Teva Pharmaceutical Industries Limited American Depositary Shares | 8.85 | 8.79 | 8.88 | 8.70 | 13.76 | 6.25 | 0.05 (0.57%) |
-9.69% | 27.89% | 9.67B | 10.29 | -13.98% | 10.67 | -17.07% |
D Sell |
| 75 | NBIX | Neurocrine Biosciences, Inc. | 97.70 | 97.12 | 98.70 | 96.66 | 136.26 | 72.14 | 0.30 (0.31%) |
-9.11% | 8.34% | 9.11B | 112.37 | -13.06% | 108.17 | -9.68% |
D Sell |
| 76 | MYL | Mylan N.V. | 14.57 | 14.63 | 14.90 | 14.54 | 23.11 | 12.75 | -0.07 (-0.48%) |
-27.51% | -24.47% | 7.53B | 15.89 | -8.32% | 17.25 | -15.52% |
D Sell |
| 77 | IONS | Ionis Pharmaceuticals, Inc. | 48.48 | 48.84 | 49.20 | 47.86 | 66.22 | 39.32 | -0.55 (-1.12%) |
-19.75% | -17.91% | 6.77B | 54.18 | -10.53% | 56.06 | -13.52% |
D Sell |
| 78 | PRGO | Perrigo Company plc Ordinary Shares | 45.67 | 45.32 | 46.11 | 45.27 | 63.86 | 40.01 | 0.04 (0.09%) |
-10.52% | -16.93% | 6.23B | 51.42 | -11.18% | 52.58 | -13.14% |
D Sell |
| 79 | GWPH | GW Pharmaceuticals Plc | 97.82 | 98.79 | 99.52 | 96.88 | 141.98 | 67.98 | -1.68 (-1.69%) |
-6.45% | -15.97% | 3.04B | 111.13 | -11.97% | 111.22 | -12.04% |
D Sell |
| 80 | IRWD | Ironwood Pharmaceuticals, Inc. - | 9.42 | 8.86 | 9.50 | 8.63 | 14.10 | 7.91 | -0.11 (-1.15%) |
-29.23% | 7.66% | 1.51B | 9.90 | -4.80% | 10.81 | -12.84% |
D Sell |
| 81 | KPTI | Karyopharm Therapeutics Inc. | 14.59 | 14.87 | 15.18 | 14.44 | 29.61 | 8.91 | -0.32 (-2.15%) |
-23.89% | 48.57% | 1.07B | 15.60 | -6.49% | 18.16 | -19.68% |
D Sell |
| 82 | ARCT | Arcturus Therapeutics Holdings Inc. | 42.73 | 41.06 | 42.86 | 40.28 | 66.24 | 8.51 | 1.68 (4.09%) |
293.10% | 310.08% | 1.04B | 49.32 | -13.37% | 31.17 | 37.09% |
D Sell |
| 83 | BTAI | BioXcel Therapeutics, Inc. | 43.04 | 42.31 | 44.14 | 41.41 | 71.50 | 3.76 | 0.63 (1.49%) |
194.59% | 472.34% | 962.16M | 45.67 | -5.75% | 35.17 | 22.38% |
D Sell |
| 84 | ENDP | Endo International plc - Ordinary Shares | 3.27 | 3.21 | 3.32 | 3.15 | 7.10 | 2.08 | 0.07 (2.19%) |
-30.28% | 2.51% | 751.50M | 3.13 | 4.40% | 4.07 | -19.63% |
D Sell |
| 85 | EGRX | Eagle Pharmaceuticals, Inc. | 41.88 | 41.14 | 42.82 | 41.14 | 64.94 | 33.80 | 0.61 (1.48%) |
-30.29% | -25.78% | 569.86M | 42.45 | -1.34% | 48.68 | -13.96% |
D Sell |
| 86 | SNDX | Syndax Pharmaceuticals, Inc. | 14.02 | 13.73 | 14.29 | 13.65 | 21.97 | 5.35 | 0.22 (1.59%) |
59.68% | 81.14% | 540.46M | 15.40 | -8.95% | 13.03 | 7.61% |
D Sell |
| 87 | ASMB | Assembly Biosciences, Inc. | 16.25 | 16.05 | 16.63 | 16.01 | 27.84 | 8.13 | 0.09 (0.56%) |
-20.58% | 52.58% | 533.89M | 20.32 | -20.02% | 19.54 | -16.84% |
D Sell |
| 88 | AERI | Aerie Pharmaceuticals, Inc. | 11.43 | 11.13 | 11.46 | 10.97 | 26.26 | 10.22 | 0.40 (3.63%) |
-52.71% | -43.81% | 531.66M | 11.81 | -3.21% | 15.79 | -27.60% |
D Sell |
| 89 | CRNX | Crinetics Pharmaceuticals, Inc. | 15.09 | 14.59 | 15.15 | 14.36 | 26.67 | 10.63 | 0.37 (2.51%) |
-39.86% | -0.26% | 496.22M | 15.14 | -0.31% | 17.91 | -15.73% |
D Sell |
| 90 | MGTX | MeiraGTx Holdings plc - Ordinary Shares | 13.26 | 12.87 | 13.31 | 12.63 | 22.32 | 8.82 | 0.43 (3.35%) |
-33.77% | -16.29% | 495.43M | 13.33 | -0.49% | 15.03 | -11.78% |
D Sell |
| 91 | MIRM | Mirum Pharmaceuticals, Inc. - common stock | 19.36 | 18.60 | 19.82 | 18.46 | 28.31 | 6.51 | 0.72 (3.86%) |
-21.04% | 99.79% | 491.72M | 21.97 | -11.87% | 18.43 | 5.06% |
D Sell |
| 92 | FIXX | Homology Medicines, Inc. | 10.60 | 10.74 | 10.80 | 10.41 | 22.50 | 9.19 | -0.16 (-1.49%) |
-48.79% | -41.31% | 479.31M | 11.77 | -9.97% | 15.15 | -30.05% |
D Sell |
| 93 | KALA | Kala Pharmaceuticals, Inc. | 7.93 | 7.94 | 8.07 | 7.66 | 14.68 | 3.24 | -0.04 (-0.50%) |
114.91% | 98.25% | 444.56M | 8.87 | -10.57% | 8.70 | -8.90% |
D Sell |
| 94 | SYRS | Syros Pharmaceuticals, Inc. - common stock | 9.56 | 9.35 | 9.72 | 9.21 | 14.69 | 4.26 | 0.18 (1.92%) |
38.35% | -8.17% | 437.48M | 11.30 | -15.43% | 8.90 | 7.44% |
D Sell |
| 95 | VYGR | Voyager Therapeutics, Inc. | 11.07 | 11.15 | 11.35 | 10.71 | 17.60 | 6.26 | -0.09 (-0.81%) |
-20.65% | -35.08% | 414.36M | 11.41 | -2.97% | 11.77 | -5.92% |
D Sell |
| 96 | BYSI | BeyondSpring, Inc. - Ordinary Shares | 13.56 | 13.53 | 13.88 | 13.43 | 21.50 | 9.38 | -0.11 (-0.80%) |
-12.52% | -20.66% | 408.26M | 12.51 | 8.37% | 14.56 | -6.89% |
D Sell |
| 97 | RIGL | Rigel Pharmaceuticals, Inc. | 2.29 | 2.29 | 2.34 | 2.27 | 5.24 | 1.23 | -0.02 (-0.87%) |
7.01% | 25.14% | 386.85M | 2.45 | -6.52% | 2.13 | 7.63% |
D Sell |
| 98 | KMDA | Kamada Ltd. - Ordinary Shares | 8.02 | 8.12 | 8.14 | 7.91 | 13.33 | 4.40 | -0.12 (-1.47%) |
17.42% | 55.13% | 357.05M | 9.21 | -12.90% | 7.53 | 6.53% |
D Sell |
| 99 | ACIU | AC Immune SA | 4.81 | 4.69 | 4.92 | 4.62 | 13.00 | 4.07 | 0.03 (0.63%) |
-43.54% | -2.63% | 345.07M | 7.18 | -33.05% | 7.48 | -35.67% |
D Sell |
| 100 | IDYA | IDEAYA Biosciences, Inc. | 11.82 | 12.24 | 12.24 | 11.22 | 19.97 | 2.95 | -0.37 (-3.04%) |
57.60% | 28.90% | 343.11M | 12.05 | -1.87% | 9.06 | 30.46% |
D Sell |
| 101 | WVE | Wave Life Sciences Ltd. - Ordinary Shares | 9.19 | 9.28 | 9.47 | 9.02 | 39.98 | 6.61 | -0.15 (-1.61%) |
14.66% | -54.88% | 335.01M | 11.27 | -18.43% | 10.05 | -8.55% |
D Sell |
| 102 | UROV | Urovant Sciences Ltd. | 9.19 | 9.12 | 9.23 | 9.04 | 15.98 | 6.55 | 0.02 (0.22%) |
-40.75% | -2.03% | 286.56M | 8.70 | 5.63% | 10.36 | -11.31% |
D Sell |
| 103 | OSMT | Osmotica Pharmaceuticals plc - Ordinary Shares | 5.40 | 5.25 | 5.47 | 5.18 | 9.67 | 2.81 | 0.13 (2.47%) |
-22.75% | 37.06% | 278.21M | 5.52 | -2.25% | 5.44 | -0.68% |
D Sell |
| 104 | AGRX | Agile Therapeutics, Inc. | 3.11 | 2.89 | 3.11 | 2.84 | 4.77 | 0.35 | 0.27 (9.51%) |
24.40% | 177.68% | 271.50M | 2.93 | 6.15% | 2.75 | 13.02% |
D Sell |
| 105 | CHMA | Chiasma, Inc. | 4.35 | 4.39 | 4.52 | 4.33 | 7.75 | 2.88 | -0.05 (-1.14%) |
-12.30% | -10.68% | 251.44M | 4.87 | -10.64% | 4.94 | -11.96% |
D Sell |
| 106 | LCI | Lannett Co Inc | 5.95 | 5.90 | 6.02 | 5.85 | 13.12 | 4.89 | 0.06 (1.02%) |
-32.54% | -46.30% | 239.31M | 5.88 | 1.23% | 7.46 | -20.20% |
D Sell |
| 107 | SPRO | Spero Therapeutics, Inc. | 9.95 | 10.21 | 11.09 | 9.89 | 14.48 | 5.25 | 0.65 (6.99%) |
3.48% | -8.72% | 210.47M | 11.44 | -13.03% | 10.64 | -6.45% |
D Sell |
| 108 | SCPH | scPharmaceuticals Inc. | 7.51 | 7.43 | 7.65 | 7.25 | 11.99 | 4.01 | 0.08 (1.08%) |
32.69% | 17.34% | 205.17M | 7.90 | -4.98% | 7.79 | -3.57% |
D Sell |
| 109 | MIST | Milestone Pharmaceuticals Inc. | 7.55 | 7.52 | 7.71 | 7.29 | 23.25 | 1.69 | 0.04 (0.53%) |
-52.84% | -60.05% | 186.56M | 8.08 | -6.61% | 9.58 | -21.19% |
D Sell |
| 110 | VERU | Veru Inc. | 2.59 | 2.72 | 2.74 | 2.58 | 4.74 | 1.85 | -0.05 (-1.89%) |
-22.69% | 23.92% | 180.95M | 2.83 | -8.52% | 3.34 | -22.42% |
D Sell |
| 111 | APTX | Aptinyx Inc. | 3.31 | 3.13 | 3.32 | 3.13 | 5.28 | 1.60 | 0.08 (2.48%) |
-3.22% | -6.23% | 155.45M | 3.63 | -8.77% | 3.51 | -5.74% |
D Sell |
| 112 | FENC | Fennec Pharmaceuticals Inc. | 5.97 | 5.87 | 6.02 | 5.69 | 10.67 | 4.20 | 0.13 (2.23%) |
-8.01% | 24.37% | 154.09M | 6.68 | -10.57% | 6.96 | -14.18% |
D Sell |
| 113 | EOLS | Evolus, Inc. | 3.81 | 3.75 | 3.85 | 3.65 | 17.68 | 3.00 | 0.07 (1.87%) |
-68.69% | -75.23% | 128.58M | 3.61 | 5.49% | 5.95 | -36.01% |
D Sell |
| 114 | ADMS | Adamas Pharmaceuticals, Inc. | 4.13 | 4.05 | 4.26 | 4.04 | 7.45 | 1.90 | 0.09 (2.23%) |
8.97% | -37.96% | 116.80M | 4.19 | -1.32% | 3.79 | 8.94% |
D Sell |
| 115 | SMMT | Summit Therapeutics plc | 3.49 | 3.50 | 3.57 | 3.25 | 5.49 | 1.18 | 0.02 (0.58%) |
118.13% | 128.43% | 112.03M | 3.50 | -0.19% | 2.80 | 24.64% |
D Sell |
| 116 | ORGS | Orgenesis Inc. | 4.98 | 5.34 | 5.34 | 4.82 | 8.20 | 2.35 | -0.01 (-0.20%) |
6.87% | 18.29% | 110.03M | 5.32 | -6.36% | 5.17 | -3.66% |
D Sell |
| 117 | LPCN | Lipocine Inc. | 1.38 | 1.38 | 1.43 | 1.36 | 3.25 | 0.30 | -0.02 (-1.43%) |
258.53% | -50.54% | 90.65M | 1.62 | -15.05% | 0.90 | 53.68% |
D Sell |
| 118 | TRVI | Trevi Therapeutics, Inc. | 4.02 | 4.10 | 4.10 | 3.89 | 8.50 | 1.33 | 0.00 (0.00%) |
7.20% | -12.42% | 73.32M | 4.43 | -9.24% | 4.21 | -4.57% |
D Sell |
| 119 | ECOR | electroCore, Inc. | 1.64 | 1.64 | 1.68 | 1.59 | 3.30 | 0.32 | 0.00 (0.00%) |
3.14% | -24.60% | 73.02M | 1.80 | -8.87% | 1.22 | 34.64% |
D Sell |
| 120 | SYBX | Synlogic, Inc. | 2.01 | 2.06 | 2.06 | 1.92 | 3.46 | 1.35 | -0.03 (-1.47%) |
-22.09% | -5.19% | 68.67M | 2.23 | -9.96% | 2.23 | -10.05% |
D Sell |
| 121 | CPIX | Cumberland Pharmaceuticals Inc. | 3.20 | 3.21 | 3.25 | 3.18 | 6.10 | 3.10 | -0.09 (-2.74%) |
-37.86% | -43.26% | 48.44M | 3.29 | -2.87% | 3.88 | -17.53% |
D Sell |
| 122 | ACER | Acer Therapeutics Inc. | 3.13 | 2.86 | 3.18 | 2.82 | 7.25 | 1.08 | 0.38 (13.82%) |
-21.95% | -5.15% | 37.29M | 3.21 | -2.64% | 3.28 | -4.55% |
D Sell |
| 123 | SNES | SenesTech, Inc. | 1.82 | 1.78 | 1.84 | 1.63 | 20.60 | 1.32 | 0.10 (5.81%) |
-83.45% | -91.08% | 6.19M | 1.70 | 6.98% | 3.66 | -50.29% |
D Sell |
| 124 | CGC | Canopy Growth Corporation | 14.50 | 14.25 | 14.80 | 14.14 | 25.97 | 9.00 | 0.29 (2.04%) |
-31.25% | -39.15% | 5.39B | 16.73 | -13.31% | 17.41 | -16.73% |
F Strong Sell |
| 125 | BHC | Bausch Health Companies Inc. | 14.88 | 15.21 | 15.26 | 14.88 | 31.97 | 11.15 | -0.39 (-2.55%) |
-50.27% | -31.43% | 5.28B | 17.06 | -12.78% | 20.25 | -26.52% |
F Strong Sell |
| 126 | RETA | Reata Pharmaceuticals, Inc. - | 94.78 | 93.40 | 95.28 | 92.21 | 257.96 | 73.38 | 1.25 (1.34%) |
-53.64% | 12.50% | 3.18B | 117.35 | -19.23% | 159.90 | -40.73% |
F Strong Sell |
| 127 | TARO | Taro Pharmaceutical Industries Ltd. Ordinary Shares | 54.53 | 54.17 | 54.93 | 53.94 | 99.69 | 53.94 | 0.12 (0.22%) |
-37.98% | -28.36% | 2.09B | 61.27 | -11.01% | 69.19 | -21.19% |
F Strong Sell |
| 128 | AMRN | Amarin Corporation plc, each representing one Ordinary Share | 4.04 | 4.00 | 4.09 | 3.89 | 26.12 | 3.36 | 0.04 (1.00%) |
-81.16% | -73.33% | 1.56B | 5.83 | -30.68% | 10.51 | -61.57% |
F Strong Sell |
| 129 | KNSA | Kiniksa Pharmaceuticals, Ltd. - | 15.55 | 15.14 | 15.73 | 14.92 | 28.67 | 5.01 | 0.13 (0.84%) |
40.60% | 78.33% | 1.06B | 17.75 | -12.38% | 18.09 | -14.03% |
F Strong Sell |
| 130 | NBRV | Nabriva Therapeutics plc - Ordinary Shares | 0.54 | 0.52 | 0.54 | 0.52 | 2.23 | 0.49 | 0.02 (3.43%) |
-59.09% | -73.27% | 1.06B | 0.66 | -17.94% | 0.89 | -39.41% |
F Strong Sell |
| 131 | ZGNX | Zogenix, Inc. | 17.95 | 17.98 | 18.44 | 17.48 | 57.22 | 16.65 | -0.05 (-0.28%) |
-65.57% | -56.22% | 995.29M | 23.64 | -24.06% | 30.84 | -41.80% |
F Strong Sell |
| 132 | CNST | Constellation Pharmaceuticals, Inc. | 19.85 | 19.70 | 20.40 | 19.32 | 59.49 | 6.01 | 0.14 (0.71%) |
-57.86% | 208.71% | 942.88M | 23.28 | -14.75% | 32.54 | -39.00% |
F Strong Sell |
| 133 | ARVN | Arvinas, Inc. | 23.51 | 22.99 | 24.00 | 22.38 | 61.57 | 15.19 | 0.52 (2.26%) |
-42.78% | 3.34% | 922.49M | 27.67 | -15.03% | 39.54 | -40.54% |
F Strong Sell |
| 134 | TLRY | Tilray, Inc. - Class 2 | 4.83 | 4.81 | 4.97 | 4.71 | 25.95 | 2.43 | 0.01 (0.21%) |
-71.80% | -81.38% | 614.27M | 6.50 | -25.73% | 10.01 | -51.77% |
F Strong Sell |
| 135 | ACB | Aurora Cannabis Inc. Common Shares | 4.68 | 4.71 | 5.10 | 4.56 | 55.68 | 4.56 | -0.10 (-2.09%) |
-81.94% | -91.56% | 540.49M | 8.92 | -47.56% | 13.71 | -65.87% |
F Strong Sell |
| 136 | MTEM | Molecular Templates, Inc. | 10.50 | 10.47 | 10.65 | 10.27 | 19.12 | 6.16 | 0.01 (0.10%) |
-24.92% | 58.61% | 524.15M | 11.56 | -9.15% | 13.90 | -24.47% |
F Strong Sell |
| 137 | RDUS | Radius Health, Inc. | 11.15 | 10.80 | 11.31 | 10.72 | 29.89 | 10.15 | 0.35 (3.24%) |
-44.69% | -57.13% | 518.16M | 12.11 | -7.94% | 15.04 | -25.89% |
F Strong Sell |
| 138 | FLXN | Flexion Therapeutics, Inc. | 10.40 | 10.84 | 10.84 | 10.23 | 22.98 | 5.01 | -0.46 (-4.24%) |
-49.76% | -25.23% | 512.75M | 12.16 | -14.44% | 12.97 | -19.84% |
F Strong Sell |
| 139 | ODT | Odonate Therapeutics, Inc. | 14.52 | 13.08 | 14.61 | 12.94 | 46.50 | 12.56 | 1.38 (10.50%) |
-55.25% | -43.70% | 466.48M | 25.72 | -43.54% | 30.05 | -51.68% |
F Strong Sell |
| 140 | APLT | Applied Therapeutics, Inc. | 20.34 | 19.68 | 20.53 | 18.80 | 57.39 | 9.76 | 0.57 (2.88%) |
-25.44% | 104.94% | 456.33M | 24.91 | -18.36% | 35.39 | -42.52% |
F Strong Sell |
| 141 | CUE | Cue Biopharma, Inc. | 15.40 | 15.07 | 15.73 | 14.88 | 31.69 | 6.95 | 0.24 (1.58%) |
-2.99% | 73.62% | 454.24M | 18.48 | -16.66% | 19.65 | -21.64% |
F Strong Sell |
| 142 | TXMD | TherapeuticsMD, Inc. | 1.61 | 1.45 | 1.62 | 1.44 | 4.00 | 0.85 | 0.14 (9.15%) |
-33.47% | -57.41% | 438.39M | 1.60 | 0.32% | 1.63 | -1.07% |
F Strong Sell |
| 143 | TCDA | Tricida, Inc. | 8.56 | 8.60 | 8.95 | 8.54 | 44.30 | 8.54 | -0.31 (-3.49%) |
-77.32% | -72.18% | 428.42M | 12.28 | -30.27% | 25.49 | -66.42% |
F Strong Sell |
| 144 | DRRX | DURECT Corporation | 1.75 | 1.72 | 1.76 | 1.67 | 3.95 | 0.95 | 0.01 (0.57%) |
-53.95% | -11.62% | 351.01M | 1.97 | -11.00% | 2.08 | -15.92% |
F Strong Sell |
| 145 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.21 | 3.17 | 3.36 | 3.02 | 5.83 | 2.55 | 0.05 (1.58%) |
-14.40% | -39.09% | 332.12M | 3.66 | -12.24% | 4.17 | -22.93% |
F Strong Sell |
| 146 | MGTA | Magenta Therapeutics, Inc. | 6.83 | 7.08 | 7.14 | 6.72 | 16.19 | 5.76 | 0.03 (0.44%) |
-54.95% | -29.02% | 329.57M | 7.23 | -5.54% | 9.57 | -28.60% |
F Strong Sell |
| 147 | CTMX | CytomX Therapeutics, Inc. | 6.69 | 6.69 | 6.79 | 6.63 | 15.44 | 3.60 | 0.00 (0.00%) |
-19.49% | -13.12% | 309.02M | 7.15 | -6.46% | 7.92 | -15.54% |
F Strong Sell |
| 148 | VRCA | Verrica Pharmaceuticals Inc. | 8.08 | 8.04 | 8.35 | 8.02 | 18.67 | 6.02 | -0.19 (-2.30%) |
-49.15% | -35.46% | 208.58M | 7.98 | 1.23% | 11.24 | -28.10% |
F Strong Sell |
| 149 | OGI | Organigram Holdings Inc. | 1.05 | 1.01 | 1.09 | 1.01 | 4.01 | 1.01 | 0.04 (3.96%) |
-57.14% | -71.39% | 204.24M | 1.24 | -15.48% | 1.79 | -41.39% |
F Strong Sell |
| 150 | AVDL | Avadel Pharmaceuticals plc each representing one Ordinary Share | 5.14 | 5.20 | 5.30 | 5.12 | 13.49 | 3.25 | -0.12 (-2.28%) |
-31.92% | 20.94% | 192.49M | 7.16 | -28.17% | 7.87 | -34.70% |
F Strong Sell |
| 151 | NYMX | Nymox Pharmaceutical Corporation | 2.60 | 2.48 | 2.64 | 2.45 | 4.79 | 1.66 | 0.09 (3.59%) |
18.18% | 37.57% | 189.07M | 2.79 | -6.70% | 2.92 | -10.93% |
F Strong Sell |
| 152 | LQDA | Liquidia Technologies, Inc. | 4.90 | 4.77 | 5.00 | 4.55 | 12.10 | 2.65 | 0.15 (3.16%) |
14.62% | 27.60% | 184.98M | 5.41 | -9.37% | 5.98 | -18.04% |
F Strong Sell |
| 153 | BFRA | Biofrontera AG | 8.00 | 8.18 | 8.18 | 7.85 | 55.00 | 5.27 | -0.09 (-1.11%) |
-23.08% | -37.06% | 179.40M | 10.26 | -22.00% | 11.18 | -28.42% |
F Strong Sell |
| 154 | OPTN | OptiNose, Inc. | 3.83 | 3.67 | 3.86 | 3.53 | 11.66 | 3.28 | 0.14 (3.79%) |
-58.46% | -47.46% | 176.15M | 4.93 | -22.35% | 5.70 | -32.84% |
F Strong Sell |
| 155 | TLC | Taiwan Liposome Company, Ltd. - ADRs | 4.55 | 4.46 | 4.62 | 4.46 | 12.65 | 2.48 | 0.00 (0.00%) |
-15.43% | -14.41% | 168.79M | 5.06 | -10.12% | 5.03 | -9.49% |
F Strong Sell |
| 156 | SLGL | Sol-Gel Technologies Ltd. | 7.24 | 7.24 | 7.37 | 7.11 | 21.00 | 5.00 | -0.06 (-0.82%) |
-57.78% | -18.19% | 147.62M | 7.61 | -4.82% | 9.04 | -19.94% |
F Strong Sell |
| 157 | APM | Aptorum Group Limited - Class A Ordinary Shares | 4.76 | 8.22 | 14.23 | 4.68 | 18.25 | 1.16 | 3.54 (290.16%) |
-69.97% | -70.08% | 137.92M | 2.69 | 76.69% | 6.03 | -21.08% |
F Strong Sell |
| 158 | VTVT | vTv Therapeutics Inc. - | 1.80 | 1.74 | 1.80 | 1.73 | 4.23 | 1.35 | 0.03 (1.69%) |
5.88% | 23.29% | 127.90M | 2.18 | -17.54% | 2.32 | -22.31% |
F Strong Sell |
| 159 | TYME | Tyme Technologies, Inc. | 0.94 | 0.97 | 0.98 | 0.93 | 2.04 | 0.86 | -0.02 (-1.82%) |
-32.86% | -36.77% | 119.54M | 1.14 | -17.37% | 1.28 | -26.39% |
F Strong Sell |
| 160 | SBBP | Strongbridge Biopharma plc - Ordinary Shares | 2.11 | 2.10 | 2.13 | 2.09 | 4.63 | 1.43 | -0.04 (-1.86%) |
0.96% | -13.17% | 114.69M | 3.31 | -36.28% | 2.94 | -28.17% |
F Strong Sell |
| 161 | ERYP | Erytech Pharma S.A. | 5.98 | 6.12 | 6.12 | 5.98 | 13.95 | 3.50 | 0.18 (3.10%) |
-18.92% | 41.37% | 108.13M | N/A | N/A% | N/A | N/A% |
F Strong Sell |
| 162 | PHAS | PhaseBio Pharmaceuticals, Inc. | 3.48 | 3.36 | 3.51 | 3.34 | 8.49 | 2.60 | 0.12 (3.57%) |
-43.04% | -23.09% | 102.11M | 3.86 | -9.86% | 4.42 | -21.21% |
F Strong Sell |
| 163 | ELOX | Eloxx Pharmaceuticals, Inc. | 2.53 | 2.80 | 2.84 | 2.50 | 8.16 | 1.44 | -0.28 (-9.96%) |
-65.63% | -43.78% | 101.55M | 3.02 | -16.21% | 3.52 | -28.05% |
F Strong Sell |
| 164 | ZYNE | Zynerba Pharmaceuticals, Inc. | 3.31 | 3.40 | 3.45 | 3.28 | 8.83 | 2.55 | -0.11 (-3.22%) |
-45.20% | -57.18% | 96.83M | 3.73 | -11.20% | 4.45 | -25.60% |
F Strong Sell |
| 165 | ABEO | Abeona Therapeutics Inc. | 1.11 | 1.15 | 1.16 | 1.09 | 5.19 | 1.07 | 0.02 (1.83%) |
-66.06% | -54.88% | 94.10M | 2.41 | -54.02% | 2.73 | -59.28% |
F Strong Sell |
| 166 | MNK | Mallinckrodt plc Ordinary Shares | 0.93 | 0.85 | 0.93 | 0.85 | 6.42 | 0.81 | 0.08 (9.41%) |
-73.35% | -58.67% | 78.67M | 1.57 | -40.60% | 2.90 | -67.91% |
F Strong Sell |
| 167 | RMTI | Rockwell Medical, Inc. | 1.05 | 1.09 | 1.09 | 1.03 | 3.85 | 1.02 | 0.01 (0.96%) |
-56.97% | -65.00% | 73.81M | 1.50 | -30.21% | 2.12 | -50.48% |
F Strong Sell |
| 168 | ASRT | Assertio Therapeutics, Inc. | 0.67 | 0.67 | 0.69 | 0.64 | 1.71 | 0.55 | 0.00 (0.27%) |
-46.40% | -48.87% | 71.75M | 0.81 | -17.00% | 0.93 | -27.83% |
F Strong Sell |
| 169 | CLSD | Clearside Biomedical, Inc. | 1.48 | 1.48 | 1.51 | 1.45 | 4.13 | 0.60 | -0.02 (-1.33%) |
-48.97% | 124.86% | 68.59M | 1.69 | -12.54% | 2.09 | -29.03% |
F Strong Sell |
| 170 | NOVN | Novan, Inc. | 0.49 | 0.51 | 0.51 | 0.48 | 3.72 | 0.22 | -0.02 (-3.92%) |
-84.49% | -81.37% | 67.36M | 0.58 | -14.90% | 0.66 | -25.30% |
F Strong Sell |
| 171 | EYPT | EyePoint Pharmaceuticals, Inc. | 0.54 | 0.54 | 0.55 | 0.52 | 2.69 | 0.46 | 0.01 (1.63%) |
-65.16% | -70.19% | 67.18M | 0.60 | -10.56% | 1.02 | -46.97% |
F Strong Sell |
| 172 | EYEN | Eyenovia, Inc. | 3.21 | 3.28 | 3.28 | 3.16 | 6.92 | 1.11 | 0.01 (0.31%) |
-28.35% | -19.75% | 65.92M | 3.66 | -12.20% | 3.47 | -7.43% |
F Strong Sell |
| 173 | SVRA | Savara, Inc. | 1.09 | 1.17 | 1.20 | 1.09 | 5.48 | 0.69 | -0.09 (-7.63%) |
-75.67% | -61.07% | 59.00M | 1.62 | -32.62% | 2.29 | -52.32% |
F Strong Sell |
| 174 | PTI | Proteostasis Therapeutics, Inc. | 1.11 | 1.09 | 1.13 | 1.07 | 4.72 | 0.70 | 0.03 (2.78%) |
-51.32% | 24.62% | 57.92M | 1.34 | -17.13% | 1.53 | -27.46% |
F Strong Sell |
| 175 | ETTX | Entasis Therapeutics Holdings Inc. | 2.10 | 2.25 | 2.28 | 2.09 | 6.35 | 1.75 | -0.15 (-6.67%) |
-57.75% | -65.85% | 57.31M | 2.80 | -24.99% | 3.46 | -39.33% |
F Strong Sell |
| 176 | ZOM | Zomedica Pharmaceuticals Corp. Common Shares | 0.10 | 0.11 | 0.11 | 0.10 | 0.50 | 0.07 | -0.00 (-1.07%) |
-69.79% | -72.38% | 57.25M | 0.13 | -23.02% | 0.19 | -48.60% |
F Strong Sell |
| 177 | SCYX | SCYNEXIS, Inc. | 4.37 | 4.50 | 4.61 | 4.35 | 14.40 | 4.34 | -0.12 (-2.67%) |
-51.98% | -59.16% | 46.33M | 5.93 | -26.33% | 7.87 | -44.45% |
F Strong Sell |
| 178 | ALNA | Allena Pharmaceuticals, Inc. | 1.21 | 1.22 | 1.24 | 1.18 | 6.30 | 0.53 | -0.01 (-0.82%) |
-55.68% | -70.42% | 46.12M | 1.37 | -11.40% | 1.73 | -30.12% |
F Strong Sell |
| 179 | HAPP | HAPPINESS BIOTECH GROUP LTD | 1.76 | 1.73 | 1.77 | 1.67 | 6.10 | 1.67 | 0.01 (0.57%) |
-61.36% | -60.89% | 44.00M | 2.21 | -20.34% | 3.18 | -44.73% |
F Strong Sell |
| 180 | IMRN | Immuron Limited | 7.35 | 7.22 | 7.35 | 6.98 | 28.99 | 1.55 | 0.27 (3.81%) |
102.48% | 179.67% | 41.17M | 9.60 | -23.41% | 5.33 | 38.03% |
F Strong Sell |
| 181 | ADIL | Adial Pharmaceuticals, Inc | 3.03 | 1.41 | 4.00 | 1.40 | 4.00 | 1.00 | 1.62 (114.89%) |
25.73% | 102.00% | 41.09M | 1.49 | 102.80% | 1.59 | 90.38% |
F Strong Sell |
| 182 | OPNT | Opiant Pharmaceuticals, Inc. | 7.60 | 7.90 | 7.95 | 7.56 | 18.23 | 7.35 | -0.35 (-4.40%) |
-47.22% | -52.35% | 32.36M | 8.79 | -13.52% | 10.66 | -28.69% |
F Strong Sell |
| 183 | NEOS | Neos Therapeutics, Inc. | 0.56 | 0.56 | 0.57 | 0.55 | 1.98 | 0.55 | 0.01 (1.08%) |
-62.91% | -63.16% | 28.01M | 0.68 | -17.96% | 0.98 | -42.90% |
F Strong Sell |
| 184 | HOTH | Hoth Therapeutics, Inc. | 1.99 | 1.85 | 1.99 | 1.83 | 7.25 | 1.77 | 0.13 (6.99%) |
-67.85% | -55.78% | 26.74M | 2.53 | -21.44% | 3.47 | -42.58% |
F Strong Sell |
| 185 | SBPH | Spring Bank Pharmaceuticals, Inc. | 1.42 | 1.42 | 1.44 | 1.38 | 4.80 | 0.80 | 0.07 (5.19%) |
-10.13% | -54.63% | 24.49M | 1.49 | -4.80% | 1.50 | -5.49% |
F Strong Sell |
| 186 | NTEC | Intec Pharma Ltd. - Ordinary Shares | 0.25 | 0.26 | 0.26 | 0.25 | 0.88 | 0.13 | 0.00 (0.08%) |
-50.00% | -67.07% | 17.74M | 0.34 | -25.57% | 0.32 | -22.98% |
F Strong Sell |
| 187 | ITRM | Iterum Therapeutics plc - Ordinary Share | 0.64 | 0.64 | 0.65 | 0.61 | 7.19 | 0.51 | -0.01 (-1.11%) |
-85.78% | -89.21% | 13.65M | 0.82 | -22.29% | 2.17 | -70.48% |
F Strong Sell |
| 188 | SXTC | China SXT Pharmaceuticals, Inc. | 0.25 | 0.24 | 0.27 | 0.24 | 1.56 | 0.22 | 0.01 (4.90%) |
-69.51% | -80.08% | 8.83M | 0.33 | -25.16% | 0.57 | -56.00% |
F Strong Sell |
| NR | AGN | Allergan plc Ordinary Shares | 193.02 | 193.01 | 193.38 | 191.64 | 202.21 | 114.27 | 0.03 (0.02%) |
1.74% | 37.82% | 63.50B | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | PPD | PPD Inc. | 35.15 | 34.81 | 35.17 | 34.30 | 35.70 | 10.61 | 0.75 (2.18%) |
17.17% | 17.17% | 12.25B | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | RLAY | Relay Therapeutics Inc. | 39.98 | 37.81 | 41.34 | 36.57 | 49.89 | 32.56 | 1.97 (5.18%) |
14.07% | 14.07% | 3.60B | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | PRNB | Principia Biopharma Inc. | 100.05 | 99.99 | 100.37 | 99.95 | 101.89 | 25.35 | 0.10 (0.10%) |
82.64% | 226.53% | 3.32B | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | PCVX | Vaxcyte Inc. | 51.50 | 52.26 | 53.40 | 51.40 | 58.47 | 17.80 | -0.31 (-0.60%) |
96.94% | 96.94% | 2.62B | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | IMAB | I-Mab ADR | 38.38 | 39.07 | 39.20 | 38.21 | 42.30 | 9.30 | -0.62 (-1.59%) |
207.04% | 207.04% | 2.19B | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | GDRX | GoodRx Holdings, Inc. | 56.00 | 59.37 | 64.22 | 53.09 | 64.22 | 45.50 | -0.79 (-1.39%) |
10.89% | 10.89% | 2.15B | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | HRMY | Harmony Biosciences Holdings Inc. | 31.25 | 34.62 | 35.55 | 31.09 | 47.37 | 30.11 | -3.68 (-10.54%) |
-15.56% | -13.43% | 1.99B | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | GBIO | Generation Bio Inc. | 30.92 | 30.04 | 32.00 | 30.04 | 32.18 | 17.00 | 0.74 (2.45%) |
25.23% | 25.23% | 1.44B | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | ALXO | ALX Oncology Holdings Inc. | 38.26 | 39.68 | 42.34 | 37.78 | 52.00 | 28.01 | -1.52 (-3.82%) |
27.53% | 27.53% | 1.41B | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | CMPS | COMPASS Pathways PLC ADR | 35.61 | 37.40 | 39.00 | 33.09 | 45.00 | 22.51 | -1.39 (-3.76%) |
22.79% | 22.79% | 1.24B | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | RPTX | Repare Therapeutics Inc. | 31.68 | 32.00 | 33.00 | 31.30 | 36.67 | 21.45 | -0.15 (-0.47%) |
2.86% | 2.86% | 1.16B | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | NNOX | Nano-X Imaging Ltd. | 24.00 | 26.00 | 26.78 | 23.81 | 66.67 | 20.25 | -2.56 (-9.64%) |
10.60% | 10.60% | 1.07B | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | ITOS | iTeos Therapeutics Inc. | 24.00 | 23.98 | 24.25 | 23.74 | 34.33 | 17.50 | -0.21 (-0.87%) |
25.98% | 25.98% | 841.08M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | CALT | Calliditas Therapeutics AB ADR | 23.42 | 23.70 | 24.30 | 23.36 | 28.38 | 19.00 | -0.58 (-2.42%) |
19.49% | 19.49% | 561.35M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | PSTX | Poseida Therapeutics Inc. | 9.00 | 9.31 | 9.31 | 8.66 | 17.62 | 7.63 | -0.36 (-3.85%) |
-41.37% | -41.37% | 556.38M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | FUSN | Fusion Pharmaceuticals Inc. | 11.80 | 11.97 | 12.55 | 11.75 | 19.00 | 11.71 | -0.30 (-2.48%) |
-30.59% | -30.59% | 491.64M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | IVA | Inventiva S.A. ADR | 11.30 | 11.47 | 11.47 | 11.26 | 15.95 | 9.01 | 0.21 (1.89%) |
-15.80% | -15.76% | 431.28M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | BITI | Biotie Therapies Cor | 25.80 | 26.52 | 26.52 | 25.69 | 27.96 | 12.43 | -0.71 (-2.68%) |
79.79% | 25.18% | 351.40M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | MTCR | Metacrine Inc. | 10.23 | 10.50 | 10.63 | 10.04 | 16.19 | 9.06 | -0.26 (-2.48%) |
-13.01% | -13.01% | 265.18M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | CMPI | Checkmate Pharmaceuticals Inc. | 10.59 | 10.62 | 10.92 | 10.36 | 16.49 | 8.61 | 0.02 (0.19%) |
-24.36% | -24.36% | 228.18M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | MNLO | Menlo Therapeutics Inc. | 1.35 | 1.37 | 1.39 | 1.30 | 7.48 | 1.00 | -0.03 (-2.17%) |
-70.91% | -71.99% | 226.38M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | PYPD | PolyPid Ltd. | 11.67 | 11.87 | 12.00 | 10.92 | 19.45 | 10.76 | 0.67 (6.09%) |
-38.58% | -38.58% | 198.93M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | LYRA | Lyra Therapeutics Inc. | 11.51 | 11.76 | 11.97 | 11.49 | 22.00 | 10.44 | -0.22 (-1.88%) |
-37.98% | -37.98% | 148.77M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | OASM | Oasmia Pharmaceutical AB | 1.55 | 1.57 | 1.57 | 1.55 | 5.70 | 0.94 | 0.03 (1.97%) |
-48.68% | -13.89% | 116.20M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | NTGN | Neon Therapeutics, Inc. | 3.07 | 2.96 | 3.09 | 2.91 | 6.25 | 0.88 | 0.23 (8.10%) |
160.17% | -49.92% | 88.93M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | AQXP | Aquinox Pharmaceuticals, Inc. | 3.68 | 3.50 | 3.84 | 3.46 | 3.84 | 2.00 | 0.21 (6.05%) |
70.37% | 16.09% | 86.62M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | ASNS | Arsanis, Inc. | 3.11 | 3.24 | 3.78 | 3.05 | 28.69 | 1.15 | -0.13 (-3.86%) |
34.05% | -86.33% | 45.54M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | PRFX | PainReform Ltd. | 4.60 | 4.70 | 4.98 | 4.50 | 7.85 | 4.50 | 0.00 (0.00%) |
-31.75% | -31.75% | 40.99M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | ANVS | Annovis Bio Inc. | 4.77 | 4.49 | 5.11 | 4.49 | 10.61 | 2.42 | 0.28 (6.24%) |
-50.26% | -50.26% | 32.76M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | SNBP | Sun Biopharma Inc. | 3.14 | 3.19 | 3.20 | 3.07 | 10.00 | 2.37 | 0.04 (1.29%) |
-33.89% | -37.20% | 30.19M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | CNSP | CNS PHARMACEUTICALS, INC. | 1.78 | 1.76 | 1.84 | 1.71 | 5.69 | 1.26 | -0.02 (-1.11%) |
-54.94% | -61.05% | 29.28M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | CORV | Correvio Pharma Corp. - Ordinary Shares (Canada) | 0.42 | 0.42 | 0.42 | 0.42 | 2.79 | 0.21 | 0.00 (0.82%) |
2.44% | -81.74% | 27.79M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | TTPH | Tetraphase Pharmaceuticals, Inc. | 2.20 | 2.24 | 2.27 | 2.18 | 8.60 | 0.56 | -0.08 (-3.51%) |
-21.71% | -68.99% | 15.98M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | AKRX | Akorn, Inc. | 0.09 | 0.18 | 0.20 | 0.09 | 5.46 | 0.09 | -0.09 (-51.01%) |
-94.00% | -97.80% | 11.98M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | CXRX | Concordia International Corp. | 0.19 | 0.19 | 0.20 | 0.19 | 1.80 | 0.19 | 0.00 (0.00%) |
-71.21% | -84.55% | 9.74M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | VVUS | VIVUS, Inc. | 0.47 | 0.49 | 0.50 | 0.46 | 4.75 | 0.44 | -0.05 (-10.29%) |
-82.72% | -86.24% | 8.33M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | SGYP | Synergy Pharmaceuticals, Inc. | 0.03 | 0.06 | 0.06 | 0.03 | 2.23 | 0.03 | -0.03 (-52.00%) |
-73.68% | -98.65% | 7.44M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | IPCI | Intellipharmaceutics International Inc. | 0.21 | 0.22 | 0.27 | 0.21 | 6.60 | 0.20 | -0.06 (-22.00%) |
-13.22% | -96.60% | 4.60M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | GEMP | Gemphire Therapeutics Inc. | 0.30 | 0.31 | 0.34 | 0.29 | 1.49 | 0.24 | 0.00 (-0.37%) |
-98.52% | -61.04% | 4.46M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | SNNA | Sienna Biopharmaceuticals, Inc. | 0.14 | 0.10 | 0.17 | 0.10 | 3.80 | 0.06 | 0.03 (34.46%) |
-93.97% | -96.10% | 4.33M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | PTX | Pernix Therapeutics Holdings, Inc. | 0.21 | 0.22 | 0.24 | 0.20 | 3.30 | 0.20 | -0.01 (-4.55%) |
-50.00% | -92.76% | 3.05M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | ARDM | Aradigm Corporation | 0.12 | 0.31 | 0.35 | 0.07 | 2.33 | 0.07 | -0.34 (-73.91%) |
-62.50% | -90.77% | 1.83M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | TRPX | Therapix Biosciences Ltd. | 0.32 | 0.36 | 0.40 | 0.30 | 4.69 | 0.25 | -0.30 (-48.90%) |
-71.33% | -87.22% | 1.11M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | ARGS | Argos Therapeutics, Inc. | 0.10 | 0.10 | 0.11 | 0.10 | 4.00 | 0.07 | 0.00 (0.00%) |
-33.33% | -97.06% | 1.06M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | PRLD | Prelude Therapeutics Inc. | 28.84 | 27.32 | 30.02 | 26.03 | 31.44 | 23.69 | 1.05 (3.78%) |
10.08% | 10.08% | N/A | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | GRAY | Graybug Vision Inc | 14.30 | 15.93 | 17.30 | 14.05 | 20.74 | 14.05 | -1.76 (-10.96%) |
-13.33% | -13.33% | N/A | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | GLSI | Greenwich LifeSciences Inc. | 4.60 | 4.94 | 4.94 | 4.06 | 5.75 | 4.06 | -0.31 (-6.31%) |
-8.00% | -8.00% | N/A | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | ORTX | Orchard Therapeutics plc | 4.18 | 4.18 | 4.29 | 4.13 | 15.93 | 4.13 | -0.03 (-0.71%) |
-69.60% | -65.02% | 406.56M | 5.11 | -18.25% | 8.96 | -53.35% |
NR Not Rated |
| NR | HOOK | HOOKIPA Pharma Inc. | 9.66 | 9.96 | 10.09 | 9.51 | 14.37 | 5.80 | -0.28 (-2.82%) |
-21.01% | 28.29% | 210.93M | 10.10 | -4.34% | 10.31 | -6.34% |
NR Not Rated |
| NR | SNDL | Sundial Growers Inc. | 0.19 | 0.19 | 0.19 | 0.18 | 5.25 | 0.17 | -0.00 (-1.40%) |
-93.69% | -95.37% | 20.19M | 0.42 | -54.56% | 1.05 | -81.94% |
NR Not Rated |
All price changes on this page include dividends and splits.